| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.25B | 10.34B | 9.84B | 8.95B | 7.52B | 7.09B |
| Gross Profit | 4.02B | 4.17B | 3.78B | 3.32B | 3.06B | 2.90B |
| EBITDA | 1.92B | 1.98B | 1.79B | 1.47B | 1.36B | 1.33B |
| Net Income | 993.94M | 1.48B | 932.98M | 1.13B | 1.06B | 967.27M |
Balance Sheet | ||||||
| Total Assets | 20.02B | 21.31B | 20.26B | 19.34B | 17.08B | 15.53B |
| Cash, Cash Equivalents and Short-Term Investments | 3.83B | 4.88B | 3.86B | 3.14B | 2.46B | 2.88B |
| Total Debt | 968.25M | 283.03M | 1.15B | 1.21B | 377.44M | 71.84M |
| Total Liabilities | 3.33B | 2.83B | 3.29B | 3.55B | 2.60B | 2.34B |
| Stockholders Equity | 16.55B | 18.33B | 16.82B | 15.65B | 14.40B | 13.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.07B | 1.18B | 1.06B | 168.82M | 379.46M |
| Operating Cash Flow | 0.00 | 1.30B | 1.42B | 1.45B | 961.47M | 1.26B |
| Investing Cash Flow | 0.00 | 403.27M | -396.26M | -1.08B | -1.59B | -801.79M |
| Financing Cash Flow | 0.00 | -1.36B | -677.73M | 312.28M | -67.44M | -227.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥28.80B | 14.51 | ― | 0.72% | ― | ― | |
79 Outperform | ¥11.33B | 8.02 | ― | 2.82% | 5.08% | 58.45% | |
72 Outperform | ¥194.20B | 15.90 | 10.28% | 2.77% | 4.61% | 1.98% | |
65 Neutral | ¥189.56B | 13.93 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥11.93B | 10.00 | ― | 6.70% | -1.89% | -12.80% | |
50 Neutral | ¥6.96B | 114.87 | ― | 1.65% | 3.81% | ― |